DUSP1 and hepatocellular carcinoma: After a surgical resection, the 5-year survival rate of DUSP1-negative patients is 18.2% compared with 65.5% in DUSP1-positive patients,77 suggesting that the expression of DUSP1 in HCC is a prominent prognostic marker for the outcome.77